09:03 AM EDT, 06/16/2025 (MT Newswires) -- US equity futures were up before Monday's opening bell, rebounding from Friday's losses fueled by the ongoing tensions between Israel and Iran, while traders looked ahead to the upcoming two-day rate policy setting Federal Open Market Committee meeting scheduled to begin Tuesday.

Dow Jones Industrial Average futures were up 0.6%, S&P 500 futures were 0.7% higher, and Nasdaq futures were up 0.8%.

Investors continued to monitor the ongoing Israel-Iran conflict, which has already entered its fourth day with both sides escalating their attacks.

Oil prices were lower, with front-month global benchmark North Sea Brent crude down 1.8% at $72.95 per barrel and US West Texas Intermediate crude 1.8% lower at $70.07 per barrel.

The Empire State Manufacturing Index, released at 8:30 am ET, came in at negative 16.0 in June after May's negative 9.2 level, compared with estimates compiled by Bloomberg for negative 6.3.

In other world markets, Japan's Nikkei closed 1.3% higher, Hong Kong's Hang Seng ended 0.7% higher, and China's Shanghai Composite finished 0.4% higher. Meanwhile, the UK's FTSE 100 was up 0.4%, and Germany's DAX index was 0.6% higher in Europe's early afternoon session.

In equities, shares of Sarepta Therapeutics ( SRPT ) were down 37% pre-bell after the company said over the weekend that it is temporarily suspending shipments of Elevidys for non-ambulatory patients with Duchenne muscular dystrophy following a second reported case of death from acute liver failure.

On the winning side, Prothena ( PRTA ) shares were up 13% after the company said its partner Roche will advance their investigational drug prasinezumab into phase 3 development as a potential treatment for early-stage Parkinson's disease.